EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- EBITDA, 2025
- $1.4B
- YoY, 2025
- −7.4%
- 5-year CAGR
- +7.2%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $1.4B | −7.4% |
| 2024 | $1.5B | +5.5% |
| 2023 | $1.5B | −11.2% |
| 2022 | $1.6B | −10.3% |
| 2021 | $1.8B | +81.6% |
| 2020 | $1.0B | −18.7% |
| 2019 | $1.2B | +49.7% |
| 2018 | $826M | −29.5% |
| 2017 | $1.2B | +42.4% |
| 2016 | $822M | — |